612
Participants
Start Date
February 1, 2025
Primary Completion Date
December 1, 2028
Study Completion Date
July 1, 2029
Statin (atorvastatin, fluvastatin, pravastatin, rosuvastatin or simvastatin)
"The intervention group receives statin treatment following the current Herseninfarct en Hersenbloeding guideline. The intensity and target value of statin treatment are determined according to this national guideline. Which statin (atorvastatin, fluvastatin, pravastatin, rosuvastatin, simvastatin) will be selected and what dose will be prescribed is left to the discretion of the treating neurologist. The statins are registered in the Netherlands and use will be according to the licenses of the products. They will be collected at the local pharmacy by the patient (following practice as usual)."
VU University of Amsterdam
OTHER
Prof. dr. Nathalie van der Velde
OTHER